General Information of Drug (ID: DM53BDW)

Drug Name
Trioxsalen
Synonyms
trioxsalen; 3902-71-4; Trioxysalen; Trisoralen; Trimethylpsoralen; 4,5',8-Trimethylpsoralen; Elder 8011; Trioxysalenum; Trioxisaleno; Trioxysalene; 2',4,8-Trimethylpsoralen; 4,5',8-Trimethylpsoralene; NSC-71047; 2,5,9-Trimethyl-7H-furo[3,2-g]chromen-7-one; UNII-Y6UY8OV51T; Trioxysalene [INN-French]; Trioxysalenum [INN-Latin]; NSC71047; Trioxisaleno [INN-Spanish]; NSC 71047; TRIOXSALIN; 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-; EINECS 223-459-0; 4,8,5'-Trimethylpsoralen; BRN 0221723; Y6UY8OV51T
Indication
Disease Entry ICD 11 Status REF
Skin sensitivity to sun N.A. Approved [1]
Vitiligo ED63.0 Approved [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C14H12O3
Canonical SMILES
CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C
InChI
1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
5585
ChEBI ID
CHEBI:28329
CAS Number
3902-71-4
TTD ID
D0FA2O
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Trioxsalen FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015